Dr. Frederick Raal and Dr. C. Michael Gibson Discuss: Phase 3 ORION-9: Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia – Results From the Phase 3 ORION-9 Trial